Cite
Prevalence of clonal hematopoiesis of indeterminate potential (CHIP) measured by an ultra-sensitive sequencing assay: Exploratory analysis of the Circulating Cancer Genome Atlas (CCGA) study
MLA
José Baselga, et al. “Prevalence of Clonal Hematopoiesis of Indeterminate Potential (CHIP) Measured by an Ultra-Sensitive Sequencing Assay: Exploratory Analysis of the Circulating Cancer Genome Atlas (CCGA) Study.” Journal of Clinical Oncology, vol. 36, May 2018, p. 12003. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........06d3f377480aada4eb1a7afdb136fad2&authtype=sso&custid=ns315887.
APA
José Baselga, Minetta C. Liu, John F. Beausang, Samuel Gross, Ling Shen, Nan Zhang, Richard Thomas Williams, Oliver Venn, Arash Jamshidi, Geoffrey R. Oxnard, Charles Swanton, Timothy J. Yeatman, Alex Aravanis, Tara Maddala, Anne-Renee Hartman, Michael V. Seiden, Darya Filippova, Kelly L. Bolton, Anton Valouev, & Earl Hubbell. (2018). Prevalence of clonal hematopoiesis of indeterminate potential (CHIP) measured by an ultra-sensitive sequencing assay: Exploratory analysis of the Circulating Cancer Genome Atlas (CCGA) study. Journal of Clinical Oncology, 36, 12003.
Chicago
José Baselga, Minetta C. Liu, John F. Beausang, Samuel Gross, Ling Shen, Nan Zhang, Richard Thomas Williams, et al. 2018. “Prevalence of Clonal Hematopoiesis of Indeterminate Potential (CHIP) Measured by an Ultra-Sensitive Sequencing Assay: Exploratory Analysis of the Circulating Cancer Genome Atlas (CCGA) Study.” Journal of Clinical Oncology 36 (May): 12003. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........06d3f377480aada4eb1a7afdb136fad2&authtype=sso&custid=ns315887.